Personalized Medicine Market Likely to Surpass ~USD 1006 billion by 2035

Global Personalized Medicine Market Forecast 2035:

According to the report, the global personalized medicine market is likely to grow from USD 484.1 Billion in 2025 to USD 1006.2 Billion in 2035 at a highest CAGR of 7.6% during the time period. The global personalized medicine market is experiencing strong growth because genomic technologies are making progress and targeted therapies are becoming more popular and healthcare systems are starting to use data analysis methods.

Healthcare providers and pharmaceutical companies use precision medicine methods to create customized treatments which match their patients' genetic makeup thereby achieving better medical results and decreased risk of harmful drug effects. The growing funding for genomics and biomarker research and the establishment of government scientific initiatives work together to speed up personalized medicine development in oncology and cardiology and rare disease treatment.

The combination of artificial intelligence and big data analytics and next-generation sequencing technology helps researchers find biomarkers and develop accurate drugs. Personalized medicine is experiencing growth in clinical decision support systems and disease risk assessment methods and patient selection processes for clinical trials. The 2024 partnership between Moderna and Merck & Co. shows how they develop their mRNA-4157/V940 personalized cancer vaccine which uses patient-specific tumor mutation data to create individualized therapies for precision oncology.

Key Driver, Restraint, and Growth Opportunity Shaping the Global Personalized Medicine Market

The healthcare sector shows increasing adoption of pharmacogenomics which enables doctors to determine appropriate medication and dosage for patients by using their genetic information. Healthcare providers use genetic testing to create treatment plans which lead to better patient outcomes and lower chances of dangerous medication side effects. The rising adoption of pharmacogenomic testing in oncology cardiology and psychiatry specialties drives healthcare systems to develop personalized treatment methods which they now implement across their operations.

The personalized medicine industry faces its main obstacle because genomic databases still lack standardization while the industry needs more bioinformatics experts to analyze complex genetic information. The healthcare sector experiences two main obstacles which hinder its ability to implement precision medicine through genomic databases since hospitals deal with different genetic data formats and their systems lack genomic platform interoperability and their staff members need better training for genomic data analysis.

The healthcare sector experiences major growth opportunities through its rising implementation of personalized medicine in both preventive healthcare and population health management. Advanced genomic testing enables identification of individuals who have high hereditary disease risk which allows healthcare providers to start preventive treatment. Color Health expanded its population genomics programs with healthcare systems in the United States to provide large-scale hereditary disease screening and personalized preventive care strategies.

Expansion of Global Personalized Medicine Market

Genomic Innovation, Precision Therapeutics Development, and Expanding Clinical Integration Driving the Global Personalized Medicine Market Expansion

The global personalized medicine market is expanding rapidly because of ongoing advancements in genomics and the creation of precise medical treatments and the growing implementation of personalized medical treatments in healthcare. Scientists can now detect genetic mutations and disease biomarkers with greater accuracy thanks to improvements in next-generation sequencing and multi-omics research and bioinformatics platforms which enable doctors to develop personalized treatment plans for their patients.
The technologies create better treatment results which decrease harmful side effects by focusing on particular molecular pathways which drive disease development. Artificial intelligence together with advanced analytics systems is becoming more important for both genomic research and drug discovery processes which drives market expansion.
AI systems can process extensive biological datasets to determine disease risk factors and discover new drug targets while creating optimized treatment plans for patients. The combination of AI technology with genomic data is speeding up the creation of targeted drugs while enhancing diagnostic precision in various medical fields. Recent industry developments create a clear path to sustainable progress. The pharmaceutical industry is directing more funding toward AI-based drug discovery platforms which enable faster development of customized medical treatments.
Notably, Eli Lilly formed a partnership with NVIDIA in 2025 to develop an advanced AI supercomputer which will expedite drug discovery research and precision medicine development through digital technology applications that reshape pharmaceutical innovation. BioNTech and other companies have made substantial financial commitments toward establishing genomic and artificial intelligence research centers to support personalized vaccine development.

Regional Analysis of Global Personalized Medicine Market

North America has the greatest requirement for personalized medicine because the region possesses advanced genomics infrastructure and strong biotechnology research capabilities and its population uses precision diagnostics and targeted therapies. The area receives advantages from its high healthcare expenditures and its pharmaceutical industry partners who work with research institutions and its regulatory system that enables biomarker-based treatments.
The National Institutes of Health reports that the United States maintains its strong funding for precision medicine projects which seek to advance personalized medical treatment. North America maintains its lead in the personalized medicine industry through its combination of major genomics companies and extensive clinical research facilities.
The personalized medicine market in Asia Pacific experiences its fastest growth as genomic research programs expand and healthcare systems adopt digital technology and governments enhance their support for precision medicine programs. The countries of China and Japan and India have begun national genome sequencing projects to improve their disease diagnostic capabilities and develop targeted therapies.
The China Precision Medicine Initiative financially backed widespread genomic studies which help improve disease prediction and development of customized medical treatments. The market in Asia Pacific will experience rapid growth because of increasing biotechnology startups and rising genetic testing awareness and expanding partnerships with international pharmaceutical companies.

Prominent players operating in global personalized medicine market include prominent companies such as Abbott Laboratories, Agilent Technologies, Inc., Biogen Inc., Caris Life Sciences, Inc., Danaher Corporation, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Foundation Medicine, Inc., GE HealthCare Technologies Inc., Genentech, Inc., Guardant Health, Inc., Illumina, Inc., International Business Machines Corporation, Invitae Corporation, NanoString Technologies, Inc., Natera, Inc., QIAGEN N.V., Tempus AI, Inc., Thermo Fisher Scientific Inc., Veracyte, Inc., along with several other key players.

The global personalized medicine market has been segmented as follows:

Global Personalized Medicine Market Analysis, by Product Type

Pharmacogenomics
Personalized Therapeutics
Personalized Diagnostics
Personalized Medical Devices
Genetic Testing Products
Digital Health & Personalized Monitoring Tools
Others

Global Personalized Medicine Market Analysis, by Technology

Diagnostics
- Companion Diagnostics
- Predictive Diagnostics
- Prognostic Diagnostics
- Screening & Risk Assessment Diagnostics
- Others
Therapeutics
- Targeted Therapeutics
- Pharmacogenomics-based Drugs
- Gene Therapy
- Cell Therapy
- Others
Personalized Medical Devices
- Wearable Monitoring Devices
- Implantable Devices
- Smart Drug Delivery Systems
- Others
Genetic Testing Products
- Direct-to-Consumer Genetic Tests
- Clinical Genetic Testing
- Carrier Testing Kits
- Others

Global Personalized Medicine Market Analysis, by Therapeutic Approach

Targeted Therapy
- Monoclonal Antibodies
- Small Molecule Targeted Drugs
- Others
Gene Therapy
- Viral Vector-based Gene Therapy
- Non-viral Gene Therapy
- Others
Cell Therapy
- Autologous Cell Therapy
- Allogeneic Cell Therapy
- Others
Immunotherapy
- CAR-T Cell Therapy
- Immune Checkpoint Inhibitors
- Others

Global Personalized Medicine Market Analysis, by Diagnostic Type

Companion Diagnostics
- Oncology Companion Diagnostics
- Pharmacogenomic Companion Diagnostics
- Others
Predictive Diagnostics
- Genetic Risk Testing
- Preventive Screening Tests
- Others
Prognostic Diagnostics
- Disease Progression Monitoring
- Survival Outcome Prediction
- Others
Monitoring Diagnostics
- Treatment Response Monitoring
- Biomarker Monitoring Tests
- Others

Global Personalized Medicine Market Analysis, by Application

Oncology
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Hematologic Malignancies
- Others
Neurology
- Alzheimer’s Disease
- Parkinson’s Disease
- Epilepsy
- Others
Cardiology
- Cardiomyopathy
- Arrhythmia
- Coronary Artery Disease
- Others
Infectious Diseases
- HIV
- Hepatitis
- Tuberculosis
- Others
Rare Genetic Disorders
- Cystic Fibrosis
- Hemophilia
- Muscular Dystrophy
- Others
Endocrine & Metabolic Disorders
- Diabetes
- Obesity
- Thyroid Disorders
- Others
Others

Global Personalized Medicine Market Analysis, by End User

Hospitals
- Public Hospitals
- Private Hospitals
- Others
Diagnostic Laboratories
- Independent Clinical Laboratories
- Specialty Genetic Testing Laboratories
- Others
Research & Academic Institutes
- University Research Centers
- Government Research Institutes
- Others
Biopharmaceutical & Biotechnology Companies
Precision Medicine Clinics
Others

Global Personalized Medicine Market Analysis, by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Specialty Clinics & Genomic Centers
Others

Global Personalized Medicine Market Analysis, by Region

North America
Europe
Asia Pacific
Middle East
Africa
South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
  - 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
  - 1.6.1. Open Natures
  - 1.6.2. Paid Databases
  - 1.6.3. Associations
- 1.7. Primary Research
  - 1.7.1. Primary Natures
  - 1.7.2. Primary Interviews with Stakeholders across Ecosystem
2. Executive Summary
- 2.1. Global Personalized Medicine Market Outlook
  - 2.1.1. Personalized Medicine Market Size (Value - US$ Bn), and Forecasts, 2021-2035
  - 2.1.2. Compounded Annual Growth Rate Analysis
  - 2.1.3. Growth Opportunity Analysis
  - 2.1.4. Segmental Share Analysis
  - 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
  - 2.5.1. Customer/ End-use Industry Assessment
  - 2.5.2. Growth Opportunity Data, 2026-2035
    - 2.5.2.1. Regional Data
    - 2.5.2.2. Country Data
    - 2.5.2.3. Segmental Data
  - 2.5.3. Identification of Potential Market Spaces
  - 2.5.4. GAP Analysis
  - 2.5.5. Potential Attractive Price Points
  - 2.5.6. Prevailing Market Risks & Challenges
  - 2.5.7. Preferred Sales & Marketing Strategies
  - 2.5.8. Key Recommendations and Analysis
  - 2.5.9. A Way Forward
3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
  - 3.1.1. Healthcare & Pharmaceutical Industry Analysis
  - 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
  - 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
4. Market Overview
- 4.1. Market Dynamics
  - 4.1.1. Drivers
    - 4.1.1.1. Advancements in genomic sequencing enable precise disease profiling and targeted therapy development.
    - 4.1.1.2. Rising prevalence of chronic and genetic diseases increases demand for personalized treatment approaches.
    - 4.1.1.3. Growing adoption of companion diagnostics and biomarker testing improves patient stratification and treatment outcomes.
  - 4.1.2. Restraints
    - 4.1.2.1. High costs of genomic testing and targeted therapies limit accessibility in many healthcare systems.
    - 4.1.2.2. Complex data integration and bioinformatics requirements create challenges in clinical adoption.
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
  - 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
  - 4.3.2. Tariffs and Standards
  - 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
  - 4.4.1. Identify Activities
  - 4.4.2. Analyze Value and Costs
  - 4.4.3. Benchmark Performance
  - 4.4.4. Optimize and Innovate
  - 4.4.5. Evaluate Customer Value
- 4.5. Cost Structure Analysis
- 4.6. Porter’s Five Forces Analysis
- 4.7. PESTEL Analysis
- 4.8. Global Personalized Medicine Market Demand
  - 4.8.1. Historical Market Size – Value (US$ Bn), 2020-2024
  - 4.8.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
    - 4.8.2.1. Y-o-Y Growth Trends
    - 4.8.2.2. Absolute $ Opportunity Assessment
5. Competition Landscape
- 5.1. Competition structure
  - 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
  - 5.2.1. Global Company Market Share
  - 5.2.2. By Region
    - 5.2.2.1. North America
    - 5.2.2.2. Europe
    - 5.2.2.3. Asia Pacific
    - 5.2.2.4. Middle East
    - 5.2.2.5. Africa
    - 5.2.2.6. South America
- 5.3. Product Comparison Matrix
  - 5.3.1. Specifications
  - 5.3.2. Market Positioning
  - 5.3.3. Pricing
6. Global Personalized Medicine Market Analysis, by Product Type
- 6.1. Key Segment Analysis
- 6.2. Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
  - 6.2.1. Pharmacogenomics
  - 6.2.2. Personalized Therapeutics
  - 6.2.3. Personalized Diagnostics
  - 6.2.4. Personalized Medical Devices
  - 6.2.5. Genetic Testing Products
  - 6.2.6. Digital Health & Personalized Monitoring Tools
  - 6.2.7. Others
7. Global Personalized Medicine Market Analysis, by Technology
- 7.1. Key Segment Analysis
- 7.2. Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
  - 7.2.1. Diagnostics
    - 7.2.1.1. Companion Diagnostics
    - 7.2.1.2. Predictive Diagnostics
    - 7.2.1.3. Prognostic Diagnostics
    - 7.2.1.4. Screening & Risk Assessment Diagnostics
    - 7.2.1.5. Others
  - 7.2.2. Therapeutics
    - 7.2.2.1. Targeted Therapeutics
    - 7.2.2.2. Pharmacogenomics-based Drugs
    - 7.2.2.3. Gene Therapy
    - 7.2.2.4. Cell Therapy
    - 7.2.2.5. Others
  - 7.2.3. Personalized Medical Devices
    - 7.2.3.1. Wearable Monitoring Devices
    - 7.2.3.2. Implantable Devices
    - 7.2.3.3. Smart Drug Delivery Systems
    - 7.2.3.4. Others
  - 7.2.4. Genetic Testing Products
    - 7.2.4.1. Direct-to-Consumer Genetic Tests
    - 7.2.4.2. Clinical Genetic Testing
    - 7.2.4.3. Carrier Testing Kits
    - 7.2.4.4. Others
8. Global Personalized Medicine Market Analysis, by Therapeutic Approach
- 8.1. Key Segment Analysis
- 8.2. Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, by Therapeutic Approach, 2021-2035
  - 8.2.1. Targeted Therapy
    - 8.2.1.1. Monoclonal Antibodies
    - 8.2.1.2. Small Molecule Targeted Drugs
    - 8.2.1.3. Others
  - 8.2.2. Gene Therapy
    - 8.2.2.1. Viral Vector-based Gene Therapy
    - 8.2.2.2. Non-viral Gene Therapy
    - 8.2.2.3. Others
  - 8.2.3. Cell Therapy
    - 8.2.3.1. Autologous Cell Therapy
    - 8.2.3.2. Allogeneic Cell Therapy
    - 8.2.3.3. Others
  - 8.2.4. Immunotherapy
    - 8.2.4.1. CAR-T Cell Therapy
    - 8.2.4.2. Immune Checkpoint Inhibitors
    - 8.2.4.3. Others
9. Global Personalized Medicine Market Analysis, by Diagnostic Type
- 9.1. Key Segment Analysis
- 9.2. Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, by Diagnostic Type, 2021-2035
  - 9.2.1. Companion Diagnostics
    - 9.2.1.1. Oncology Companion Diagnostics
    - 9.2.1.2. Pharmacogenomic Companion Diagnostics
    - 9.2.1.3. Others
  - 9.2.2. Predictive Diagnostics
    - 9.2.2.1. Genetic Risk Testing
    - 9.2.2.2. Preventive Screening Tests
    - 9.2.2.3. Others
  - 9.2.3. Prognostic Diagnostics
    - 9.2.3.1. Disease Progression Monitoring
    - 9.2.3.2. Survival Outcome Prediction
    - 9.2.3.3. Others
  - 9.2.4. Monitoring Diagnostics
    - 9.2.4.1. Treatment Response Monitoring
    - 9.2.4.2. Biomarker Monitoring Tests
    - 9.2.4.3. Others
10. Global Personalized Medicine Market Analysis, by Application
- 10.1. Key Segment Analysis
- 10.2. Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
  - 10.2.1. Oncology
    - 10.2.1.1. Breast Cancer
    - 10.2.1.2. Lung Cancer
    - 10.2.1.3. Colorectal Cancer
    - 10.2.1.4. Hematologic Malignancies
    - 10.2.1.5. Others
  - 10.2.2. Neurology
    - 10.2.2.1. Alzheimer’s Disease
    - 10.2.2.2. Parkinson’s Disease
    - 10.2.2.3. Epilepsy
    - 10.2.2.4. Others
  - 10.2.3. Cardiology
    - 10.2.3.1. Cardiomyopathy
    - 10.2.3.2. Arrhythmia
    - 10.2.3.3. Coronary Artery Disease
    - 10.2.3.4. Others
  - 10.2.4. Infectious Diseases
    - 10.2.4.1. HIV
    - 10.2.4.2. Hepatitis
    - 10.2.4.3. Tuberculosis
    - 10.2.4.4. Others
  - 10.2.5. Rare Genetic Disorders
    - 10.2.5.1. Cystic Fibrosis
    - 10.2.5.2. Hemophilia
    - 10.2.5.3. Muscular Dystrophy
    - 10.2.5.4. Others
  - 10.2.6. Endocrine & Metabolic Disorders
    - 10.2.6.1. Diabetes
    - 10.2.6.2. Obesity
    - 10.2.6.3. Thyroid Disorders
    - 10.2.6.4. Others
  - 10.2.7. Others
11. Global Personalized Medicine Market Analysis, by End User
- 11.1. Key Segment Analysis
- 11.2. Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
  - 11.2.1. Hospitals
    - 11.2.1.1. Public Hospitals
    - 11.2.1.2. Private Hospitals
    - 11.2.1.3. Others
  - 11.2.2. Diagnostic Laboratories
    - 11.2.2.1. Independent Clinical Laboratories
    - 11.2.2.2. Specialty Genetic Testing Laboratories
    - 11.2.2.3. Others
  - 11.2.3. Research & Academic Institutes
    - 11.2.3.1. University Research Centers
    - 11.2.3.2. Government Research Institutes
    - 11.2.3.3. Others
  - 11.2.4. Biopharmaceutical & Biotechnology Companies
    - 11.2.4.1. Precision Medicine Clinics
    - 11.2.4.2. Others
12. Global Personalized Medicine Market Analysis, by Distribution Channel
- 12.1. Key Segment Analysis
- 12.2. Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, by Distribution Channel, 2021-2035
  - 12.2.1. Hospital Pharmacies
  - 12.2.2. Retail Pharmacies
  - 12.2.3. Online Pharmacies
  - 12.2.4. Specialty Clinics & Genomic Centers
  - 12.2.5. Others
13. Global Personalized Medicine Market Analysis and Forecasts, by Region
- 13.1. Key Findings
- 13.2. Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
  - 13.2.1. North America
  - 13.2.2. Europe
  - 13.2.3. Asia Pacific
  - 13.2.4. Middle East
  - 13.2.5. Africa
  - 13.2.6. South America
14. North America Personalized Medicine Market Analysis
- 14.1. Key Segment Analysis
- 14.2. Regional Snapshot
- 14.3. North America Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 14.3.1. Product Type
  - 14.3.2. Technology
  - 14.3.3. Therapeutic Approach
  - 14.3.4. Diagnostic Type
  - 14.3.5. Application
  - 14.3.6. End User
  - 14.3.7. Distribution Channel
  - 14.3.8. Country
    - 14.3.8.1. USA
    - 14.3.8.2. Canada
    - 14.3.8.3. Mexico
- 14.4. USA Personalized Medicine Market
  - 14.4.1. Country Segmental Analysis
  - 14.4.2. Product Type
  - 14.4.3. Technology
  - 14.4.4. Therapeutic Approach
  - 14.4.5. Diagnostic Type
  - 14.4.6. Application
  - 14.4.7. End User
  - 14.4.8. Distribution Channel
- 14.5. Canada Personalized Medicine Market
  - 14.5.1. Country Segmental Analysis
  - 14.5.2. Product Type
  - 14.5.3. Technology
  - 14.5.4. Therapeutic Approach
  - 14.5.5. Diagnostic Type
  - 14.5.6. Application
  - 14.5.7. End User
  - 14.5.8. Distribution Channel
- 14.6. Mexico Personalized Medicine Market
  - 14.6.1. Country Segmental Analysis
  - 14.6.2. Product Type
  - 14.6.3. Technology
  - 14.6.4. Therapeutic Approach
  - 14.6.5. Diagnostic Type
  - 14.6.6. Application
  - 14.6.7. End User
  - 14.6.8. Distribution Channel
15. Europe Personalized Medicine Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. Europe Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 15.3.1. Product Type
  - 15.3.2. Technology
  - 15.3.3. Therapeutic Approach
  - 15.3.4. Diagnostic Type
  - 15.3.5. Application
  - 15.3.6. End User
  - 15.3.7. Distribution Channel
  - 15.3.8. Country
    - 15.3.8.1. Germany
    - 15.3.8.2. United Kingdom
    - 15.3.8.3. France
    - 15.3.8.4. Italy
    - 15.3.8.5. Spain
    - 15.3.8.6. Netherlands
    - 15.3.8.7. Nordic Countries
    - 15.3.8.8. Poland
    - 15.3.8.9. Russia & CIS
    - 15.3.8.10. Rest of Europe
- 15.4. Germany Personalized Medicine Market
  - 15.4.1. Country Segmental Analysis
  - 15.4.2. Product Type
  - 15.4.3. Technology
  - 15.4.4. Therapeutic Approach
  - 15.4.5. Diagnostic Type
  - 15.4.6. Application
  - 15.4.7. End User
  - 15.4.8. Distribution Channel
- 15.5. United Kingdom Personalized Medicine Market
  - 15.5.1. Country Segmental Analysis
  - 15.5.2. Product Type
  - 15.5.3. Technology
  - 15.5.4. Therapeutic Approach
  - 15.5.5. Diagnostic Type
  - 15.5.6. Application
  - 15.5.7. End User
  - 15.5.8. Distribution Channel
- 15.6. France Personalized Medicine Market
  - 15.6.1. Country Segmental Analysis
  - 15.6.2. Product Type
  - 15.6.3. Technology
  - 15.6.4. Therapeutic Approach
  - 15.6.5. Diagnostic Type
  - 15.6.6. Application
  - 15.6.7. End User
  - 15.6.8. Distribution Channel
- 15.7. Italy Personalized Medicine Market
  - 15.7.1. Country Segmental Analysis
  - 15.7.2. Product Type
  - 15.7.3. Technology
  - 15.7.4. Therapeutic Approach
  - 15.7.5. Diagnostic Type
  - 15.7.6. Application
  - 15.7.7. End User
  - 15.7.8. Distribution Channel
- 15.8. Spain Personalized Medicine Market
  - 15.8.1. Country Segmental Analysis
  - 15.8.2. Product Type
  - 15.8.3. Technology
  - 15.8.4. Therapeutic Approach
  - 15.8.5. Diagnostic Type
  - 15.8.6. Application
  - 15.8.7. End User
  - 15.8.8. Distribution Channel
- 15.9. Netherlands Personalized Medicine Market
  - 15.9.1. Country Segmental Analysis
  - 15.9.2. Product Type
  - 15.9.3. Technology
  - 15.9.4. Therapeutic Approach
  - 15.9.5. Diagnostic Type
  - 15.9.6. Application
  - 15.9.7. End User
  - 15.9.8. Distribution Channel
- 15.10. Nordic Countries Personalized Medicine Market
  - 15.10.1. Country Segmental Analysis
  - 15.10.2. Product Type
  - 15.10.3. Technology
  - 15.10.4. Therapeutic Approach
  - 15.10.5. Diagnostic Type
  - 15.10.6. Application
  - 15.10.7. End User
  - 15.10.8. Distribution Channel
- 15.11. Poland Personalized Medicine Market
  - 15.11.1. Country Segmental Analysis
  - 15.11.2. Product Type
  - 15.11.3. Technology
  - 15.11.4. Therapeutic Approach
  - 15.11.5. Diagnostic Type
  - 15.11.6. Application
  - 15.11.7. End User
  - 15.11.8. Distribution Channel
- 15.12. Russia & CIS Personalized Medicine Market
  - 15.12.1. Country Segmental Analysis
  - 15.12.2. Product Type
  - 15.12.3. Technology
  - 15.12.4. Therapeutic Approach
  - 15.12.5. Diagnostic Type
  - 15.12.6. Application
  - 15.12.7. End User
  - 15.12.8. Distribution Channel
- 15.13. Rest of Europe Personalized Medicine Market
  - 15.13.1. Country Segmental Analysis
  - 15.13.2. Product Type
  - 15.13.3. Technology
  - 15.13.4. Therapeutic Approach
  - 15.13.5. Diagnostic Type
  - 15.13.6. Application
  - 15.13.7. End User
  - 15.13.8. Distribution Channel
16. Asia Pacific Personalized Medicine Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. Asia Pacific Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 16.3.1. Product Type
  - 16.3.2. Technology
  - 16.3.3. Therapeutic Approach
  - 16.3.4. Diagnostic Type
  - 16.3.5. Application
  - 16.3.6. End User
  - 16.3.7. Distribution Channel
  - 16.3.8. Country
    - 16.3.8.1. China
    - 16.3.8.2. India
    - 16.3.8.3. Japan
    - 16.3.8.4. South Korea
    - 16.3.8.5. Australia and New Zealand
    - 16.3.8.6. Indonesia
    - 16.3.8.7. Malaysia
    - 16.3.8.8. Thailand
    - 16.3.8.9. Vietnam
    - 16.3.8.10. Rest of Asia Pacific
- 16.4. China Personalized Medicine Market
  - 16.4.1. Country Segmental Analysis
  - 16.4.2. Product Type
  - 16.4.3. Technology
  - 16.4.4. Therapeutic Approach
  - 16.4.5. Diagnostic Type
  - 16.4.6. Application
  - 16.4.7. End User
  - 16.4.8. Distribution Channel
- 16.5. India Personalized Medicine Market
  - 16.5.1. Country Segmental Analysis
  - 16.5.2. Product Type
  - 16.5.3. Technology
  - 16.5.4. Therapeutic Approach
  - 16.5.5. Diagnostic Type
  - 16.5.6. Application
  - 16.5.7. End User
  - 16.5.8. Distribution Channel
- 16.6. Japan Personalized Medicine Market
  - 16.6.1. Country Segmental Analysis
  - 16.6.2. Product Type
  - 16.6.3. Technology
  - 16.6.4. Therapeutic Approach
  - 16.6.5. Diagnostic Type
  - 16.6.6. Application
  - 16.6.7. End User
  - 16.6.8. Distribution Channel
- 16.7. South Korea Personalized Medicine Market
  - 16.7.1. Country Segmental Analysis
  - 16.7.2. Product Type
  - 16.7.3. Technology
  - 16.7.4. Therapeutic Approach
  - 16.7.5. Diagnostic Type
  - 16.7.6. Application
  - 16.7.7. End User
  - 16.7.8. Distribution Channel
- 16.8. Australia and New Zealand Personalized Medicine Market
  - 16.8.1. Country Segmental Analysis
  - 16.8.2. Product Type
  - 16.8.3. Technology
  - 16.8.4. Therapeutic Approach
  - 16.8.5. Diagnostic Type
  - 16.8.6. Application
  - 16.8.7. End User
  - 16.8.8. Distribution Channel
- 16.9. Indonesia Personalized Medicine Market
  - 16.9.1. Country Segmental Analysis
  - 16.9.2. Product Type
  - 16.9.3. Technology
  - 16.9.4. Therapeutic Approach
  - 16.9.5. Diagnostic Type
  - 16.9.6. Application
  - 16.9.7. End User
  - 16.9.8. Distribution Channel
- 16.10. Malaysia Personalized Medicine Market
  - 16.10.1. Country Segmental Analysis
  - 16.10.2. Product Type
  - 16.10.3. Technology
  - 16.10.4. Therapeutic Approach
  - 16.10.5. Diagnostic Type
  - 16.10.6. Application
  - 16.10.7. End User
  - 16.10.8. Distribution Channel
- 16.11. Thailand Personalized Medicine Market
  - 16.11.1. Country Segmental Analysis
  - 16.11.2. Product Type
  - 16.11.3. Technology
  - 16.11.4. Therapeutic Approach
  - 16.11.5. Diagnostic Type
  - 16.11.6. Application
  - 16.11.7. End User
  - 16.11.8. Distribution Channel
- 16.12. Vietnam Personalized Medicine Market
  - 16.12.1. Country Segmental Analysis
  - 16.12.2. Product Type
  - 16.12.3. Technology
  - 16.12.4. Therapeutic Approach
  - 16.12.5. Diagnostic Type
  - 16.12.6. Application
  - 16.12.7. End User
  - 16.12.8. Distribution Channel
- 16.13. Rest of Asia Pacific Personalized Medicine Market
  - 16.13.1. Country Segmental Analysis
  - 16.13.2. Product Type
  - 16.13.3. Technology
  - 16.13.4. Therapeutic Approach
  - 16.13.5. Diagnostic Type
  - 16.13.6. Application
  - 16.13.7. End User
  - 16.13.8. Distribution Channel
17. Middle East Personalized Medicine Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Middle East Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 17.3.1. Product Type
  - 17.3.2. Technology
  - 17.3.3. Therapeutic Approach
  - 17.3.4. Diagnostic Type
  - 17.3.5. Application
  - 17.3.6. End User
  - 17.3.7. Distribution Channel
  - 17.3.8. Country
    - 17.3.8.1. Turkey
    - 17.3.8.2. UAE
    - 17.3.8.3. Saudi Arabia
    - 17.3.8.4. Israel
    - 17.3.8.5. Rest of Middle East
- 17.4. Turkey Personalized Medicine Market
  - 17.4.1. Country Segmental Analysis
  - 17.4.2. Product Type
  - 17.4.3. Technology
  - 17.4.4. Therapeutic Approach
  - 17.4.5. Diagnostic Type
  - 17.4.6. Application
  - 17.4.7. End User
  - 17.4.8. Distribution Channel
- 17.5. UAE Personalized Medicine Market
  - 17.5.1. Country Segmental Analysis
  - 17.5.2. Product Type
  - 17.5.3. Technology
  - 17.5.4. Therapeutic Approach
  - 17.5.5. Diagnostic Type
  - 17.5.6. Application
  - 17.5.7. End User
  - 17.5.8. Distribution Channel
- 17.6. Saudi Arabia Personalized Medicine Market
  - 17.6.1. Country Segmental Analysis
  - 17.6.2. Product Type
  - 17.6.3. Technology
  - 17.6.4. Therapeutic Approach
  - 17.6.5. Diagnostic Type
  - 17.6.6. Application
  - 17.6.7. End User
  - 17.6.8. Distribution Channel
- 17.7. Israel Personalized Medicine Market
  - 17.7.1. Country Segmental Analysis
  - 17.7.2. Product Type
  - 17.7.3. Technology
  - 17.7.4. Therapeutic Approach
  - 17.7.5. Diagnostic Type
  - 17.7.6. Application
  - 17.7.7. End User
  - 17.7.8. Distribution Channel
- 17.8. Rest of Middle East Personalized Medicine Market
  - 17.8.1. Country Segmental Analysis
  - 17.8.2. Product Type
  - 17.8.3. Technology
  - 17.8.4. Therapeutic Approach
  - 17.8.5. Diagnostic Type
  - 17.8.6. Application
  - 17.8.7. End User
  - 17.8.8. Distribution Channel
18. Africa Personalized Medicine Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Africa Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 18.3.1. Product Type
  - 18.3.2. Technology
  - 18.3.3. Therapeutic Approach
  - 18.3.4. Diagnostic Type
  - 18.3.5. Application
  - 18.3.6. End User
  - 18.3.7. Distribution Channel
  - 18.3.8. Country
    - 18.3.8.1. South Africa
    - 18.3.8.2. Egypt
    - 18.3.8.3. Nigeria
    - 18.3.8.4. Algeria
    - 18.3.8.5. Rest of Africa
- 18.4. South Africa Personalized Medicine Market
  - 18.4.1. Country Segmental Analysis
  - 18.4.2. Product Type
  - 18.4.3. Technology
  - 18.4.4. Therapeutic Approach
  - 18.4.5. Diagnostic Type
  - 18.4.6. Application
  - 18.4.7. End User
  - 18.4.8. Distribution Channel
- 18.5. Egypt Personalized Medicine Market
  - 18.5.1. Country Segmental Analysis
  - 18.5.2. Product Type
  - 18.5.3. Technology
  - 18.5.4. Therapeutic Approach
  - 18.5.5. Diagnostic Type
  - 18.5.6. Application
  - 18.5.7. End User
  - 18.5.8. Distribution Channel
- 18.6. Nigeria Personalized Medicine Market
  - 18.6.1. Country Segmental Analysis
  - 18.6.2. Product Type
  - 18.6.3. Technology
  - 18.6.4. Therapeutic Approach
  - 18.6.5. Diagnostic Type
  - 18.6.6. Application
  - 18.6.7. End User
  - 18.6.8. Distribution Channel
- 18.7. Algeria Personalized Medicine Market
  - 18.7.1. Country Segmental Analysis
  - 18.7.2. Product Type
  - 18.7.3. Technology
  - 18.7.4. Therapeutic Approach
  - 18.7.5. Diagnostic Type
  - 18.7.6. Application
  - 18.7.7. End User
  - 18.7.8. Distribution Channel
- 18.8. Rest of Africa Personalized Medicine Market
  - 18.8.1. Country Segmental Analysis
  - 18.8.2. Product Type
  - 18.8.3. Technology
  - 18.8.4. Therapeutic Approach
  - 18.8.5. Diagnostic Type
  - 18.8.6. Application
  - 18.8.7. End User
  - 18.8.8. Distribution Channel
19. South America Personalized Medicine Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. South America Personalized Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 19.3.1. Product Type
  - 19.3.2. Technology
  - 19.3.3. Therapeutic Approach
  - 19.3.4. Diagnostic Type
  - 19.3.5. Application
  - 19.3.6. End User
  - 19.3.7. Distribution Channel
  - 19.3.8. Country
    - 19.3.8.1. Brazil
    - 19.3.8.2. Argentina
    - 19.3.8.3. Rest of South America
- 19.4. Brazil Personalized Medicine Market
  - 19.4.1. Country Segmental Analysis
  - 19.4.2. Product Type
  - 19.4.3. Technology
  - 19.4.4. Therapeutic Approach
  - 19.4.5. Diagnostic Type
  - 19.4.6. Application
  - 19.4.7. End User
  - 19.4.8. Distribution Channel
- 19.5. Argentina Personalized Medicine Market
  - 19.5.1. Country Segmental Analysis
  - 19.5.2. Product Type
  - 19.5.3. Technology
  - 19.5.4. Therapeutic Approach
  - 19.5.5. Diagnostic Type
  - 19.5.6. Application
  - 19.5.7. End User
  - 19.5.8. Distribution Channel
- 19.6. Rest of South America Personalized Medicine Market
  - 19.6.1. Country Segmental Analysis
  - 19.6.2. Product Type
  - 19.6.3. Technology
  - 19.6.4. Therapeutic Approach
  - 19.6.5. Diagnostic Type
  - 19.6.6. Application
  - 19.6.7. End User
  - 19.6.8. Distribution Channel
20. Key Players/ Company Profile
- 20.1. Abbott Laboratories
  - 20.1.1. Company Details/ Overview
  - 20.1.2. Company Financials
  - 20.1.3. Key Customers and Competitors
  - 20.1.4. Business/ Industry Portfolio
  - 20.1.5. Product Portfolio/ Specification Details
  - 20.1.6. Pricing Data
  - 20.1.7. Strategic Overview
  - 20.1.8. Recent Developments
- 20.2. Agilent Technologies, Inc.
- 20.3. Biogen Inc.
- 20.4. Caris Life Sciences, Inc.
- 20.5. Danaher Corporation
- 20.6. Exact Sciences Corporation
- 20.7. F. Hoffmann-La Roche Ltd.
- 20.8. Foundation Medicine, Inc.
- 20.9. GE HealthCare Technologies Inc.
- 20.10. Genentech, Inc.
- 20.11. Guardant Health, Inc.
- 20.12. Illumina, Inc.
- 20.13. International Business Machines Corporation
- 20.14. Invitae Corporation
- 20.15. NanoString Technologies, Inc.
- 20.16. Natera, Inc.
- 20.17. QIAGEN N.V.
- 20.18. Tempus AI, Inc.
- 20.19. Thermo Fisher Scientific Inc.
- 20.20. Veracyte, Inc.
- 20.21. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF

PRICING DETAILS

Single-User Upto 2 Users - [PDF + Excel Only]

USD 4150

Multi-User Upto 10 Users - [PDF + Excel + PPT]

USD 5950

Enterprise-User Company-wide - [Report Pack + Benchmark + 6M Update]

USD 7750

Related Report

Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation